Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA

NCT00920725 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Ketoacidosis

Interventions

DRUG: Insulin (Aspart Insulin [Novolog], Regular Insulin)

Sponsor

Rush University Medical Center

Collaborators

[object Object]